To assess whether the defect in B16F10 tumor control was due to NK cell dysfunction, we adoptively transferred IL-2 activated NK cells from TRPM2+/+ and TRPM2−/− mice into B16F10 tumor-bearing TRPM2−/− mice. Here, IL2 is linked to neoplasm.